Therefore, TH agonists could principally represent promising drugs for the treatment of hepatic steatosis and obesity-related diseases, but harmful effects of the studied agonists on heart, bone, and muscle have, so far, prevented their use as therapeutic compounds (18,78). Here, TH is linked to fatty liver disease.